Skip to content
Open access

Correction: Obinutuzumab as salvage anti-CD20 therapy in poly-refractory difficult-to-treat seropositive rheumatoid arthritis

Unknown authors
Oct 2026 · Rheumatology Advances in Practice · Vol 10 · 0 citations
Medicine

Abstract

[This corrects the article DOI: 10.1093/rap/rkag089.].

Read PDF

Similar papers

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.